Nanobiotix S.A. Share Price & Technical Analysis
NBTX · $40.18 (-6.90%)
Healthcare / Biotechnology
$40.18
-6.90%
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small c…
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
15% return in May, 57% avg return in past 3 year May month.
55% return in 2026, 118% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -7% | 48% | -5% | 5% | 15% | – | – | – | – | – | – | – | 55% |
| 25 | 13% | 3% | 0% | 0% | 21% | 12% | 44% | 27% | 128% | 11% | 8% | 9% | 275% |
| 24 | 6% | -22% | 3% | -9% | 21% | -32% | 4% | 7% | -2% | -28% | -26% | -6% | -84% |
| 23 | 30% | -12% | 0% | -40% | 130% | -2% | 51% | 18% | -6% | -26% | -11% | 33% | 164% |
| 22 | -8% | -3% | -3% | -20% | -12% | -24% | -30% | 33% | -8% | 14% | 3% | -10% | -67% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Uptrend · Neutral
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$2.31B
P/E ratio
—
52W high
$57.14
52W low
$3.66
Volume
1,11,800
Beta
0.58
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Nanobiotix S.A. share price today?
- Nanobiotix S.A. (NBTX) last traded around $40.18 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NBTX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NBTX. Download the app for real-time alerts.
- How can I analyze Nanobiotix S.A. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.